Pivotal Therapeutics Inc. is a publicly traded company (OTCQX: PVTTF) (CNSX: PVO) with offices in Woodbridge, Ontario Canada and Boca Raton, Florida US. Pivotal is a specialty pharmaceutical company with a focus on Omega-3 therapies for cardiovascular disease (CVD) and overall health. The company currently has two commercial products: VASCAZEN® available in the US by prescription only and OMAZEN® available for sale as a natural health product in Canada.The company's lead product VASCAZEN® is a prescription only Medical Food for the treatment of an Omega-3 Deficiency (OM3D) in patients with cardiovascular disease. The company's second product OMAZEN® is an ultra pure Omega-3 for the maintenance of good health.
VASCAZEN® is a prescription only Medical Food specifically formulated for the dietary management of an Omega-3 Deficiency in cardiovascular patients. VASCAZEN® is a >90% pure Omega-3 consisting of a proprietary blend of Omega-3 fatty acids. In recent clinical trials,the VASCAZEN® formulation demonstrated to be highly effective in correcting an Omega-3 Deficiency and reducing various risk factors associated with cardiovascular disease. VASCAZEN® is the only prescription Omega-3 Medical Food available in the US and is protected by a series of both issued and pending US and foreign patents..
OMAZEN® is a greater than 90% pure, pharmaceutical grade Omega-3 for the maintenance of good health. OMAZEN® has a proprietary formulation delivering optimal levels of Omega-3 that promotes an increase in blood flow, reduced inflammation and positive effects on blood lipids contributing to the maintenance of good health.